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Background. Heparan sulfate proteoglycans (HSPGs) are control elements in Wnt signaling, which bind extracellularly to Wnt
ligands and regulate their ability to interact with signal transduction receptors on the cell surface. Sulf-1 and Sulf-2 are novel
extracellular sulfatases that act on internal glucosamine-6-sulfate (6S) modifications within HSPGs and thereby modulate HSPG
interactions with various signaling molecules, including Wnt ligands. Emerging evidence indicates the importance of
reactivated Wnt signaling in a number of cancers, including pancreatic adenocarcinoma. Principle Findings. Both Sulf
proteins were upregulated in human pancreatic adenocarcinoma tumors and were broadly expressed in human pancreatic
adenocarcinoma cell lines. Expression of human extracellular sulfatases Sulf-1 and Sulf-2 enhanced Wnt signaling in
a reconstituted system. Three of four pancreatic adenocarcinoma cell lines tested exhibited autocrine Wnt signaling, in that
extracellular Wnt ligands were required to initiate downstream Wnt signaling. Exposure of these pancreatic adenocarcinoma
cells to a catalytically inactive form of Sulf-2 or siRNA-mediated silencing of endogenous Sulf-2 inhibited both Wnt signaling
and cell growth. Sulf-2 silencing in two of these lines resulted in markedly reduced tumorigenesis in immunocompromised
mice. Conclusions/Significance. We have identified the Sulfs as potentiators of autocrine Wnt signaling in pancreatic cancer
cells and have demonstrated their contribution to the growth and tumorigenicity of these cells. Since the Sulfs are extracellular
enzymes, they would be attractive targets for therapy of pancreatic cancer. Our results run counter to the prevailing view in
the literature that the Sulfs are negative regulators of tumorigenesis.
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INTRODUCTION
Pancreatic adenocarcinoma is the most common form of
pancreatic cancer and one of the most deadly malignancies with
a 5 year survival rate of 3% and a median survival of less than
6 months [1]. There has been recent interest in the role of
embryonic signaling pathways in cancer. Considerable evidence
has demonstrated that these pathways remain functional in
a limited number of cells within the adult and that dysregulation
of these pathways contributes to the formation and persistence of
tumors [2,3]. In this regard, the reactivation of Notch, Hedgehog
and Wnt pathways have attracted recent interest in cancers of the
GI tract, including pancreatic adenocarcinoma [2,4,5].
The dysregulation of Wnt signaling in pancreatic adenocarci-
noma is the focus of the present study. Wnts comprise a large
family of secreted proteins, which regulate cell growth, apoptosis,
motility and differentiation during embryonic development [3]. In
brief, activation of the canonical Wnt pathway is initiated by
binding of Wnt ligands to signal transduction receptors on the cell
surface, which leads to the accumulation of non-phosphorylated b-
catenin in the cytoplasm. After its translocation to the nucleus, b-
catenin forms a complex with members of the TCF/LEF family of
transcription factors, and activates target genes [3].
Wnt signaling was first implicated in cancer through the analysis
of mammary gland tumorigenesis induced by the mouse mammary
tumor virus (MMTV) [6]. A high proportion of the tumors were due
to activation of Wnt1 expression through insertion of the MMTV
provirus into the wnt1 gene. Tumorigenesis is thought to be based on
an autocrine Wnt transforming pathway in which Wnt ligand
expressionbymammaryepithelialcellsprovidesagrowthstimulusto
the same cells. Recently autocrine Wnt signaling was demonstrated
in breast cancer, ovarian cancer and myeloma cell lines, [7,8]. This
mechanism, in which extracellular Wnt ligands provide an essential
stimulus for cell proliferation, is distinct from that commonly found
in human colon cancer and several other forms of cancer, in which
constitutive activation of Wnt signaling is a consequence of
mutations in downstream cytoplasmic elements such as APC,
CTNN1 (encoding b-catenin) or AXIN2 [3].
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molecules are very rare in pancreatic adenocarcinoma [9]. Yet,
aberrant activation of Wnt signaling is a significant feature of human
pancreatic adenocarcinoma, as revealed by the nuclear localization
of b-catenin in a significant fraction (30–65%) of tumors [9,10].
Consistent with the histochemical evidence, biochemical analysis has
established a marked elevation of total b-catenin and its increased
nuclearlocalizationintwo-thirdsofpancreaticadenocarcinomas[9].
Moreover, in mechanistic studies with pancreatic adenocarcinoma
cell lines, inhibition of Wnt signaling resulted in reduced cell
proliferation and survival in vitro [11].
An area of current interest are the extracellular regulatory
elements in the Wnt signaling pathway. Among these are secreted
Wnt antagonists such as Frizzled related proteins (sFRP), Wnt
inhibitory factor (WIF) and the Dickkopf family (DKK) [12].
Downregulation of any of these antagonists initiates Wnt
activation and contributes to several forms of cancer [12]. A class
of extracellular proteins that positively regulates Wnt activity are
heparan sulfate proteoglycans (HSPGs). Glypicans, for example,
are required for Wnt signaling during development in Drosophila
and vertebrates [13]. HSPGs are also necessary in examples of
Wnt-dependent tumor formation [14,15]. The myriad functions of
HSPGs in growth and differentiation of cells [16] are mediated
through their ability to bind to a diverse repertoire of growth
factors and morphogens. Binding depends on the sulfation pattern
of glucosamine (N-, 3-O, and 6-O positions) and uronic acid (2-O-
position) within the attached heparan sulfate chains. [16]. 6-O-
sulfation (6S) of glucosamine is of particular importance in the
binding of many important ligands to HPSGs, including the Wnts
[17–19]. A newly appreciated mechanism for regulating signaling
by these ligands is by post-synthetic ‘‘editing’’ of the 6S pattern of
HSPGs through the action of a class of extracellular sulfatases
known as the Sulfs [20].
QSulf-1, the first member of the Sulf family to be described,
was discovered in an analysis of muscle development in the
quail embryo [20]. This was followed by the description of its
orthologues in rat [21], mouse, and human [22] and the discovery
of the closely-related homologue, Sulf-2 [22]. The Sulfs are neutral
pH optimum endosulfatases that remove 6-O-sulfate from internal
glucosamine residues in highly sulfated subdomains of heparin/
HSPGs [18,19,22,23]. The initial studies of QSulf-1 revealed
a positive role in the regulation of Wnt signaling during muscle
specification in the quail embryo [20]. This activity depends on the
ability of QSulf-1 to reduce the interaction of Wnt ligands with
HSPGs. The authors proposed a two state model in which HS
chains form a high affinity HS-Wnt complex, which sequesters
Wnt from interacting with its signal transduction receptors. The
affinity of Wnt for HS is weakened when QSulf-1 modifies the 6S
pattern of the HS chains, allowing the initiation of Wnt signaling
[19].
Sulf-dependent promotion of Wnt signaling has also been
observed in other developmental events [24]. In vitro evidence
suggests that the Sulfs can promote other signaling pathways
including angiogenesis and BMP signaling [23,25]. Importantly,
sulf null mice show reduced body mass [26,27]. This phenotype is
consistent with positive regulatory roles for the Sulfs during
normal development.
The discovery that canonical Wnt signaling is activated in
pancreatic adenocarcinoma (see above) has focused our attention
on the possible involvement of the Sulfs in this cancer. In the
present study, we demonstrate upregulation of both Sulf proteins
in pancreatic adenocarcinoma tumors. Using human pancreatic
adenocarcinoma cancer cell lines, we establish a role for Sulf-2 in
promoting autocrine Wnt signaling, in vitro cell growth and
tumorigenicity. This positive contribution of a Sulf to Wnt-
dependent tumor growth is in striking contrast to several reports in
which the enforced expression of Sulfs antagonizes other signaling
pathways (e.g. FGF-2, and HGF) in tumor cells and suppresses cell
growth [28–34].
RESULTS
Sulf-1 and Sulf-2 are upregulated in human
pancreatic cancer
Mining of public DNA microarray datasets and a quantitative
PCR study establish that SULF1 transcripts are upregulated in
human pancreatic cancer (Table 1). The latter study found that
the mean level of SULF1 mRNA was 22.5-fold greater in the
cancer tissue (n=31) than in normal pancreas (n=19) [31]. In situ
hybridization localized expression of SULF1 to tubular structures,
likely representing invasive carcinoma.
To determine if Sulf proteins were expressed by pancreatic
adenocarcinoma in surgical specimens, we stained sections from
seven archived cases with Sulf-1 and Sulf-2 antibodies and an IgG
control (Figure 1 A and B). Benign interlobular ducts on the same
tissue sections as the invasive carcinoma served as an internal
control. In 7/7 cases, the malignant epithelial cells generally
showed moderate to strong staining for Sulf-1 (Figure 1B). For
Sulf-2, 4/7 cases showed strong staining of these cells, 2/7 cases
had moderate staining and 1 case was negative. Most benign ducts
showed no staining or only trace staining for Sulf-1 (<54%) or
Sulf-2 (<88%). Focal staining for Sulf-1 or Sulf-2 was seen in
a minority of the benign ducts. Diffuse weak staining of fibroblasts
for both Sulfs was observed in some areas of stroma, usually in
association with inflammatory cells. There was no staining with
the IgG control.
Next, we determined expression of the Sulfs in human
pancreatic adenocarcinoma cell lines by using RT-PCR to survey
a panel of 24 cell lines. These were derived from either primary or
metastatic pancreatic adenocarcinomas [5]. SULF1 transcripts
Table 1. SULF1 mRNA expression in human pancreatic cancers
..................................................................................................................................................
Study Comparison Result
Li et al., 2005 [31] normal pancreas (19 specimen) vs. pancreatic cancer
(31 specimen)
N22 of 31 cancer specimens had higher SULF1 mRNA levels
than in highest normal. mean SULF1 mRNA level was 22.5-
fold higher in cancer vs. normal
Su et al., 2001 [50] pancreatic adenocarcinoma (6 specimens) N5/6 samples showed upregulation of SULF1 mRNA relative to
its mean level in 100 primary tumors of 11 different kinds
(p=0.039)
Iacobuzio-Donahu et al., 2003 [39]
(www.oncomine.org)
normal pancreas (5) vs. pancreatic adenocarcinoma (12) NSULF1 mRNA level in adenocarcinomas was 2.8 std deviations
above that in normal pancreas (p=5.5610
26)
doi:10.1371/journal.pone.0000392.t001
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PLoS ONE | www.plosone.org 2 April 2007 | Issue 4 | e392were detected by RT-PCR in 12/24 and SULF2 transcripts in 21/
24 of these lines (Figure 1C). To examine expression at the protein
level, we investigated 4 of these cell lines, 3 of which were positive
for both SULF transcripts (CFPAC-1, HS766T, L3.6sl) and 1
which was positive for only SULF2 (BxPC-3). We performed
immunoblots on detergent lysates and conditioned medium (CM)
derived from these cells (Figure 1D). Sulf-1 protein was detected in
only one cell line (HS766T cells), whereas Sulf-2 protein was present
in all 4. In detergent lysates, the molecular weight of the major
species was 130 kDa, which corresponds to an unprocessed form for
both proteins [22]. Sulf-2 protein was released into CM by all 4 cell
lines. In contrast, Sulf-1 was not detected in HS766T CM. As
previously observed for several breast carcinoma cell lines [25], Sulf-
2 protein was detected in CM as a processed 75 kDa component.
Sulf-1 and Sulf-2 promote Wnt signaling
QSulf-1 has been shown to promote activation of Wnt signaling
pathways in response to exogenous Wnt ligands [20]. We chose to
study the effects of the human Sulfs on Wnt signaling in a similar
reconstituted system [20]. We overexpressed the Sulfs in HEK
293T and co-cultured these cells with fibroblasts that expressed
either Wnt1 or Wnt4. Wnt signaling activity was measured by the
TCF-luciferase reporter system (TOPflash/FOPflash), a standard
method for measuring b-catenin-dependent transcriptional acti-
vation [20]. Expression of each Sulf augmented Wnt signaling in
response to either Wnt ligand, whereas mock-transfected HEK
293T cells did not respond (supplementary figure, Fig. S1). Thus,
both HSulfs, like QSulf-1 [20], can promote Wnt signaling.
Expression of sFRP-2 inhibits Wnt signaling in
pancreatic adenocarcinoma cell lines
Previous work has established active Wnt signaling within a series
of the pancreatic adenocarcinoma cell lines, including the 4 lines
above [M. Pasca di Magliano and M. Hebrok, unpublished
observations]. To determine whether Wnt signaling in these 4 lines
was autocrine in nature, we employed secreted Frizzled-related
protein-2 (sFRP-2) as an extracellular Wnt antagonist [35,36]. We
transiently transfected the cell lines with a cDNA for sFRP-2 or
with the empty vector (ctrl) and measured Wnt activity by the
TCF-luciferase reporter assay. sFRP-2 expression diminished Wnt
signaling <60% in 3 of the lines but had no effect on CFPAC-1
cells (Figure 2). These results establish that the BxPC-3, HS766T
and L3.6sl cells possess an autocrine Wnt signaling pathway.
Catalytically inactive human sulfatase protein
inhibits Wnt signaling and cell growth
We next asked if the endogenous Sulfs in these cell lines were
directly involved in Wnt signaling. When we overexpressed the
Sulfs, there was no effect on Wnt signaling (data not shown). Since
Figure 1. Detection of Sulf expression in pancreatic adenocarcinoma cell lines and tumors. A: Representative serial sections of pancreatic
adenocarcinoma were stained with Sulf-1, Sulf-2 and control IgG. Benign ducts were compared to areas of invasive carcinoma on the same section. B:
Quantitative tabulation of Sulf immunohistochemistry results in pancreatic adenocarcinoma cases (0=no or trace staining,1=moderate
staining,2=strong staining, ND=not determined). C: RNA was isolated from 24 adenocarcinoma cell lines, cDNA was prepared, and subjected to
PCR with primers for SULF1 and SULF2 and b-ACTIN as loading control. D: Immunoblots were performed on cell lysates and conditioned medium (CM)
using antibodies against Sulf-1 (upper panel) and Sulf-2 (middle and lower panel). Only Sulf-2 protein was detected in the CM.
doi:10.1371/journal.pone.0000392.g001
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asked whether there might be inhibitory effects if we expressed
catalytically inactive forms of these proteins. We have previously
shown that mutation of two cysteines in the sulfatase domain of
each Sulf eliminated sulfatase activity [22]. We transfected a cDNA
encoding inactive Sulf-1 (S1DCC), Sulf-2 (S2DCC) or empty
vector (ctrl) into each of the 4 cell lines and again measured Wnt
activity. As shown in Figure 3A, expression of either inactive Sulf
inhibited Wnt activity <50% in all but CFPAC-1 cells. The 3
responding lines were the same that exhibited autocrine Wnt
signaling (Figure 2). The fact that either inactive Sulf exerted
equivalent effects on these pancreatic cancer cell lines suggests
functional redundancy of the two enzymes.
We next asked whether the exogenous addition of catalytically
inactive Sulf protein would also interfere with Wnt signaling. As
a source of Sulf-2 protein, we used HEK 293T cells which were
stably transfected either with wild-type human Sulf-2 (S2) or
catalytically inactivated Sulf-2 (S2DCC) [25]. We also used the
parental HEK 293T cells (293T) as controls. The stable
transfectants secreted the active and inactive Sulfs at comparable
levels (data not shown). We incubated the pancreatic adenocar-
cinoma cells for 16 hours with CM from these cells or with control
medium and compared Wnt signaling. Exposure to the inactive
Sulf-2 protein (S2DCC) inhibited Wnt signaling in the same 3 cell
lines that were responsive to transfection with the S2DCC cDNA
(Figure 3B), whereas CFPAC cells did not show an effect. The
addition of medium, conditioned with active Sulf-2 protein, did
not promote Wnt signaling over the basal level.
Next, we set up a co-culture system to examine the effects of
recombinant Sulf protein on cell growth of the same cell lines. The
pancreatic cancer cells were seeded at low density on transwell
filters above feeder layers, which consisted of parental HEK 293T
cells or HEK 293T expressing active or inactive Sulf-2. Cell counts
were monitored for the next several days. The results paralleled
the suppressive effect we observed on Wnt signaling. Thus, as
compared to control medium, S2DCC CM inhibited the growth of
BxPC-3, HS766T and L3.6sl cells (Figure 3C) but had no effect on
CFPAC-1 cells. In contrast, active Sulf-2 did not promote or
inhibit cell growth of any of the lines.
Lentiviral shRNA silencing of Sulf-2 in pancreatic
adenocarcinoma cells reduces Wnt signaling, cell
proliferation, and cell survival
To further investigate the role of Sulf-2 in Wnt signaling and cell
growth, we used shRNA methodology to silence the expression of
Sulf-2 in these cells. We employed three shRNA constructs: two
independent constructs targeting Sulf-2 (1413 and 1143) and
a control (ctrl). These constructs were used in different vector
backgrounds in which the presence or absence of GFP allowed us
to monitor expression of the shRNAs (see MATERIALS AND
METHODS). Transduced cells were sorted for GFP expression
and subsequently analyzed for Sulf-2 expression. The 1143 and
1413 constructs (pLV-1143, pLV-1413) produced 80% and 90%
reductions of Sulf-2 protein, respectively, in L3.6sl cells, relative to
the control shRNA (pLV-ctrl) (Figure 4A). There was no reduction
of the protein in the pLV-ctrl treated cells relative to untreated
cells (data not shown). The pLV-1413 construct produced a similar
reduction in BxPC3 cells in two different vector backgrounds (pLV
and pSico).
Inactivation of Wnt signaling results in decreased levels of
activated b-catenin (N-terminally non-phosphorylated) in the
nucleus [3]. We therefore isolated the nuclear fraction of Sulf-2
silenced and control cells (BxPC-3 and L3.6sl) and analyzed levels
of activated b-catenin. There was a <80% decrease of b-catenin
in Sulf-2 silenced BxPC-3 cells, and a <30% reduction in L3.6sl
cells (Figure 4B). We also quantified Wnt activity using the TCF-
luciferase reporter system. Consistent with the b-catenin result,
this assay confirmed that Wnt signaling was substantially inhibited
in the Sulf-2 silenced cells relative to control-treated cells for both
BxPC-3 and L3.6sl cells (Figure 4C). Again, BxPC-3 cells showed
stronger inhibition (52% with pLV-1413) than the L3.6sl cells
(35% inhibition with pLV-1413 or pLV-1143).
We determined the effects of Sulf-2 silencing on cell pro-
liferation by measuring the incorporation of 5-bromodeoxyuridine
(BrdU) into the cells. There was a 25–30% reduction of cells
undergoing S-phase in L3.6sl, BxPC3, and HS766T cells, and only
a 5% reduction in CFPAC-1 cells (Figure 5A). Additionally, we
performed apoptosis assays by measuring annexin V staining. The
Sulf-2 silenced BxPC-3 cells showed an increase in apoptosis of
33%, whereas the L3.6sl cells showed increases of 65% and 79%
with two independent shRNAs (Figure 5B).
To examine cell growth over time in Sulf-2 silenced cells, we
compared growth of cells in which Sulf-2 was silenced with non-
transduced parental cells in a mixed culture. In parallel co-
cultures, we compared the growth of control shRNA-transduced
cells with parental non-transduced cells. For both of the Sulf-2
specific shRNAs, the non-silenced parental L3.6sl cells pro-
gressively overtook the silenced cells with time in culture. Similar
results were seen with the BxPC-3 cells (Figure 5D). In contrast,
there was no change in the ratio of the control-transduced cells to
parental cells over time (Figure 5C).
Silencing of Sulf-2 inhibits tumor growth in vivo
To determine the effects of Sulf-2 silencing on the tumorigenicity
of L3.6sl and BxPC-3 cells in vivo, we compared the growth of
tumors that formed in immunocompromised mice with or without
silencing of Sulf-2. Nude mice (CD-1) were injected subcutane-
ously with either pLV-ctrl or pLV-1413 transduced cells 1 week
after transduction. Tumor size was followed with time by external
palpation. At the end of the experiment, animals were sacrificed
and tumor weights were measured. As shown in Figure 6, tumors
derived from Sulf-2 silenced cells (L3.6sl or BxPC-3) grew at
a markedly slower rate than those derived from the control cells
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Figure 2. Autocrine Wnt signaling in pancreatic adenocarcinoma cell
lines. The indicated pancreatic adenocarcinoma cell lines were
transfected with sFRP-2 cDNA (sFRP-2) or control vector (ctrl) and the
TOP/FOPflash reporter system. Wnt activity was determined by
luciferase activity. The values shown are the means6SD’s for 3
independent determinations. Differences between sFRP and control
were significant in the Student t-test with p values of,0.002 for BxPC-3,
HS766T and L3.6sl.
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Figure 3. The effects of inactive Sulfs on Wnt signaling on Wnt signaling and cell growth. A: Four pancreatic adenocarcinoma cell lines as
indicated were transiently transfected with cDNAs encoding either a catalytically inactive form of Sulf-1 (‘‘S1DCC’’) or a catalytically inactive form of
Sulf-2 (‘‘S2DCC’’) or with the empty vector (‘‘control’’). The mutants were made by replacing two adjacent cysteines with alanines. Wnt signaling was
determined by utilizing the TOP/FOPflash reporter system. The values shown are the means6SD’s for 4 independent determinations and differences
between mutant and control cells were statistically significant with p values,0.02 for BxPC-3, HS766T and L3.6sl cells (Student t-test). B: The
pancreatic adenocarcinoma cell lines were cultured with conditioned medium derived from each of the following: parental HEK-293 cells (‘‘control’’),
HEK 293T cells stably expressing wild-type Sulf-2 (denoted ‘‘Sulf-2’’), or expressing a catalytically inactive form of Sulf-2 (‘‘S2DCC’’). Wild-type Sulf-2
protein and the mutant were present in the conditioned medium of the two producing cells at approximately equivalent levels. Wnt signaling was
determined as before with the TCF-luciferase reporter assay. The values shown are the means6SD’s for 3 independent determinations and
differences between Sulf-2 mutant and control were statistically significant for BxPC-3 (p=0.002), HS766T (p=0.01) and L3.6sl (p=9610
26) (Student
t-test). C: The pancreatic adenocarcinoma cell lines were cultured in a transwell system over feeder layers consisting of: medium alone (‘‘Medium’’);
parental HEK 293T cells (‘‘HEK 293T’’); HEK 293T cells stably producing wild-type Sulf-2 (‘‘Sulf-2’’); or a catalytically inactive form of Sulf-2 (‘‘S2DCC’’).
Cell growth was monitored by hemacytometer counting for 4 days. The values shown are the means6SD’s for 3 independent determinations.
doi:10.1371/journal.pone.0000392.g003
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correspondingly reduced in weight with no overlap of the two
groups for either cell line (Figure 6C).
DISCUSSION
The prevailing view in the literature has been that the Sulfs are
negative regulators of tumor cell growth. A number of reports
demonstrated that over-expression of Sulf-1 [28–34] or Sulf-2 [32]
in tumor cell lines inhibited growth factor signaling in response to
several factors, including FGF-2, HB-EGF, and HGF. Moreover,
the tumorigenicity of Sulf-overexpressing cells in immunocompro-
mized mice was diminished [31,32,34]. The negative effects of
Sulfs on FGF-2 signaling are consistent with the known
requirement for 6S on HSPGs in the FGF-2 signaling complex
[37]. These cell line findings have led to the suggestion that down-
regulation of Sulfs could provide tumor cells with a growth
advantage in certain settings. This model may have validity for the
significant subset (two-thirds) of ovarian cancer cases [28] and the
minor subset (29%) of hepatocellular carcinoma cases [30] in
which SULF1 expression is downregulated relative to that in
normal tissue. However, the model is problematic for the sizeable
subsets of several cancers which show increases in SULF
expression. Thus, for example, SULF1 is upregulated in significant
subsets of breast cancer [38], pancreatic cancer [31,39] (Table 1)
lung adenocarcinoma [40] and hepatocellular carcinoma [30],
while SULF2 is upregulated in multiple myeloma [32], breast
cancer and CNS cancers [41].
To understand the significance of upregulated SULF expression
in a cancer, we chose to focus on pancreatic adenocarcinomas
because of clear evidence associating this cancer with canonical
Wnt signaling, a signaling pathway known to be positively
regulated by the Sulfs during development (see above). Consistent
with the transcript expression data (Table 1), we found that both
Sulfs were strongly expressed at the protein level by malignant
epithelial cells in pancreatic adenocarcinoma. To facilitate
investigation of these enzymes in pancreatic cancer, we examined
SULF expression in a large panel of pancreatic adenocarcinoma
cell lines and found widespread expression, especially of SULF2.
We chose 4 lines for study, all of which expressed Sulf-2 protein
and one of which expressed both Sulfs. Previous studies have
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PLoS ONE | www.plosone.org 6 April 2007 | Issue 4 | e392shown that proliferation and survivalof 3 of these(BxPC-3, HS766T
and L3.6sl) depend on activated Wnt signaling [M. Pasca di
Magliano and M. Hebrok, unpublished observations]. We showed
that Wnt signaling was markedly inhibited by overexpressing
recombinant sFRP-2 in these cell lines. Moreover, overexpression
of catalytically inactive Sulf-2 in the same lines resulted in a marked
inhibition of Wnt activity, and exposure of the cells to inactive Sulf-2
protein during culture inhibited both Wnt signaling and growth.
These results are consistent with Wnt-ligand dependent growth of
these cells (‘‘autocrine Wnt signaling’’), which is modulated by the
extracellular Sulfs. It is plausible that the CFPAC-1 cell line, which
was refractory to all of these treatments, carries an activating
mutation in downstream elements of the Wnt signaling pathway that
would bypass the need for extracellular Wnt ligands and the Sulfs. It
should be noted that the Sulfs represent an additional example of an
extracellular factor, which modulates Wnt signaling. However, in
contrast to the extracellular Wnt antagonists such as DKK1 and
sFRPs, which are suppressed in certain tumors, the Sulfs are
upregulated in pancreatic adenocarcinomas and exert a positive
effect on Wnt signaling. Here we demonstrate that the Sulfs enhance
the activity of the Wnt pathway in tumor cells, a function
demonstrated previously only in a developmental context.
Our results indicate that catalytically inactive Sulf-2 can act as
a dominant-negative mutant. There are several plausible mechan-
isms to explain this effect. One is that inactive Sulf-2 acts as
a ‘‘substrate trapping mutant’’ such that it competes with the
active enzyme for binding to heparan sulfate substrates, thereby
blocking the ability of the enzyme to alter the substrate and
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observation that certain sulfatases (e.g., arylsulfatase A), can form
homo-oligomers [42]. The Sulfs have the potential to form
multimers due to their predicted coiled-coil structure [22]. Thus,
the catalytically inactive protein could interfere with the general
activity when incorporated into a multimer. Thirdly, the inactive
Sulf might displace the wild-type enzyme from a subdomain in the
plasma membrane where it is normally targeted for optimal
function. The cell surface associations of QSulf-1 and QSulf -2 are
known to require the hydrophilic domains of the molecules, but
the molecular details have not been worked out [43].
To rigorously test the involvement of the Sulfs in Wnt signaling
and tumor growth, we used lentiviral shRNA systems to silence
Sulf-2 expression in four pancreatic adenocarcinoma cell lines.
This approach contrasts with previous studies in which function of
a Sulf was investigated in cancer cell lines by overexpressing it in
cells that lacked it [28–34]. Sulf-2 silenced cells (BxPC-3, L3.6sl,
HS766T) exhibited a decrease in DNA synthesis and an increase
in apoptosis (BxPC-3, L3.6sl). Moreover, the silenced cells
exhibited reduced Wnt activity by two criteria. Consistent with
these findings, silenced cells showed a marked growth disadvan-
tage in co-cultures with control cells. The dominant negative
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293T cells (Figure 3C) suggest that Sulf-2 can function in trans,a t
least in the setting of artificial overexpression of the protein.
Therefore, one might predict rescue of the silenced cells by the
secreted Sulf-2 protein from control cells. We conclude that the
rescue effect was at best partial, since the silenced cells grew at
a slower rate than the control cells in the mixed culture.
The in vitro results were extended into a tumorigenesis model in
nude mice by demonstrating that Sulf-2-silenced L3.6sl and BxPC-
3 cells formed smaller tumors with time. Our evidence for the
involvement of the Sulfs in the growth and tumorigenesis of
pancreatic adenocarcinoma cells is most complete for Sulf-2. It
remains to be seen what impact silencing Sulf-1 will have on a cell
type that expresses this enzyme alone or in combination with Sulf-
2 (e.g., HS766T cells). One might predict functional redundancy
of the two enzymes based on the ability of either inactive Sulf to
exert equivalent dominant negative effects (Fig. 3A). Moreover, the
two enzymes exhibit indistinguishable enzymatic activities against
heparin/heparan sulfate in vitro [22,43], although there is recent
genetic evidence for cooperative activities [26].
The present findings are the first to implicate the Sulfs as
positive regulators of growth in a cancer, namely pancreatic
tumors that are driven by autocrine Wnt signaling. Further
xenograft experiments with cell lines and primary tumor cells,
together with studies of mouse models of pancreatic adenocarci-
noma [44], are needed to test this proposed role for the Sulfs.
Accumulating evidence indicates that a number of other cancers
also depend on autocrine Wnt signaling for growth [6–8,15,45–
47]. Since SULF upregulation has been found in a number of these
cancers, the potential role of these enzymes in enhancing
tumorigenesis deserves exploration in these systems. As extracel-
lular enzymes, the Sulfs would be very attractive therapeutics
targets for both small molecule and antibody approaches.
MATERIALS AND METHODS
Constructs
Sulf cDNA constructs were cloned in our lab as described [22].
For Sulf-2 siRNA experiments, we used the target region GCT-
GAAGCTGCATAAGTGC (1413) or GGAGTGGTGGTGT-
CAATAA (1143) and AACAGTCGCGTTTGCGACTGG as
control. The hairpin oligonucleotides were cloned into the plas-
mids pSico or pLVTHM as described [48,49]. To activate the
shRNA in pSico, transduced BxPC-3 cells were sorted for GFP
expression and subsequently transiently transfected with a cre
recombinase plasmid to excise the CMV-GFP reporter cassette
and thus activate expression of the shRNAs. 10 days after cre-
recombinase transfection, cells were sorted for GFP negative cells
and analyzed for HSulf-2 expression and used for further
experiments. The pPGK-cre-bpa plasmid was generously pro-
vided by Dr. M.S. German and the pLVTHM was provided by
Dr. S.S. Sidhu.
Preparation of Anti-Sulf-1 Polyclonal Antibodies
Polyclonal antibodies were produced by ProSci. Rabbits
were immunized and purified as described [25] with a peptide,
derived from the predicted human Sulf-1 sequence (H1.5:
CPKNLDVGNKDGGSYDLHRGO-COOH, where C denotes
the cysteine residue added for coupling).
Histology and immunoblotting assays
Under Committee for Human Experimentation approval (H1060-
27616-01), archived formalin-fixed paraffin-embedded tissue
blocks were obtained for seven cases of invasive pancreatic
adenocarcinoma. Hydrated 4 mm sections were subject to heat
induced epitope retrieval (109 in a pressure cooker) and stained
with either purified polyclonal rabbit Ab H1.5 or Ab H2.3. A
purified polyclonal rabbit antibody directed to HSVI/II served as
a negative control. Antibody binding was visualized by the Dako
Envision (+) system (cat #K4011). Areas of invasive adenocarci-
noma were identified by architectural features (infiltration and
associated desmoplasia) and confirmed by cytologic features
(nuclear enlargement, pleomorphism, and hyperchromasia) on
H&E-stained sections. Interlobular ducts without any of the above
features served as an internal control.
Cell lysates were prepared by extraction of washed cells in RIPA
buffer (150 mM NaCl, 1% Triton X-100, 0.1% SDS, protease
inhibitor cocktail (Roche), 50 mM Tris-HCl pH 7.5 for 20 min
on ice. Insoluble material was pelleted by centrifugation for
30 minutes at 21.000 g. For analysis of conditioned medium (CM),
the CM was concentrated on a Centricon30 microconcentrator
(Millipore Corp.). For extracting nuclear proteins, we used the
Compartmental Protein Extraction Kit (Chemicon International/
Millipore). Equal protein concentrations were loaded based on
quantification with the BCA
TM Protein Assay (Pierce, Rockford,
IL) following the manufacturer’s procedure. Total cell lysates or
CM were subjected to SDS-PAGE on 7.5 or 10% polyacrylamide
gels (BioRad) blotted to ProBlott
TM (Applied Biosystems).
Immunoblotting was performed as described [22] with affinity
purified rabbit polyclonal antibodies H1.5 for human Sulf-1 and
H2.3 or H2.1 for human Sulf-2 [25]. For detection of b-catenin we
used anti-active-b-catenin antibody (clone 8E7, Millipore), for
histone detection we used anti-Histone H1 (clone AE-4, Millipore).
For detection of actin we used the antibody ‘‘Actin (I-19)’’ from
Santa Cruz Biotechnology Inc.
Cell culture and gene transduction
Human pancreatic adenocarcinoma cell lines CFPAC-1, HS766T,
L3.6sl and the human embryonic kidney cells HEK 293 were
maintained in Dulbecco’s modified Eagle’s (DMEM) medium
supplemented with 10% fetal bovine serum. Human pancreatic
adenocarcinoma cell line BxPC-3 was maintained in RPMI
medium supplemented with 10% fetal bovine serum. Sulf2 and
S2DCC expressing HEK 293 cells were generated and grown as
described [25]. We have previously verified the elimination of
enzymatic activity in the S2DCC mutant [25]. We employed the
same strategy for achieving stable expression of Sulf-1 and
catalytically inactivated Sulf-1 in HEK 293 cells. For transient
transfections, Fugene (Roche) or for Cre transfection the Basic
Nucleofector Kit for Primary Mammalian Epithelial Cells
(Amaxa) was used. Lentivirus production and infection was done
as described [48,49]. To generate pSico transduced cell lines 15–
20 GFP positive colonies were picked and co-cultured. 10 days
after Cre-transfection cell populations were sorted by FACS for
GFP negative cells. NIH 3T3 fibroblast cells, expressing Wnts
were generously provided by Dr. A. Kispert, Germany.
RT-PCR and Data mining
For analyzing Sulf expression patterns in published gene micro-
array studies, we used the oncomine database (www.oncomine.
org) and http://source.Stanford.edu. Total RNAs were extracted
from cells using Trizol (Invitrogen) and cDNA was generated using
Superscript II Reverse Transcriptase (Invitrogen). For RT-PCR
the following primer combinations were used: Sulf-1 forward: 59-
CTCACAGTCCGGCAGAGCACGCGGAAC-39, and reverse:
59-CACGGCGTTGCTGCTATCTGCCAGCATCC-39. For
Sulf-2, the following primers were used: forward 59-GAAAA-
Sulfs and Pancreatic Cancer
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ATCTGGTGCTTCTTTTGGGATGCGGGAG-39. SYBR
Green real time PCR was done, using the primer pairs: Sulf1F:
59-TTGAAGAGAGCATAATTGGA-
ATGG-39, Sulf1R: 59-CTGCATGTCATTTGCCA AGTTT-39
and Sulf2F: 59-C CTCTTCCCAAACGCATCTC-39 and 59-
GCGCATGAT CCAGTGTTTGT-39. The conditions for de-
naturing, annealing and extension of the template cDNA were as
follows: 94uC for 30 sec, 55uC for 30 sec and 72uC for 1 min for
35 cycles. PCR products were separated by electrophoresis on 2%
agarose gels and visualized with ethidium bromide.
Luciferase reporter assays
Cells transfected with either TOPflash or FOPflash and Renilla-
Luciferase control plasmid (Promega). After 48 hrs cells analyzed
utilizing the Dual Luciferase Reporter Assay system (Promega).
Luciferase activity was normalized to control Renilla-Luciferase
activity. To determine Sulf influence on Wnt signaling in HEK
293T cells, cells were transfected with TOP/FOPflash and Renilla
control plasmid and incubated with CM from Wnt1 or Wnt4
transfected 3T3 human fibroblasts for 24 hours.
Co-culture experiment
Co-culture experiments were performed in transwell plates with
24 well inserts with 5 mm pore size (Corning Incorporated).
HEK293T cells were plated in the wells as feeder layer and one
day later 1–2610
3 cells of the pancreatic adenocarcinoma cell
lines were plated in the inserts.
BrdU incorporation assay
BrdU incorporation was measured by flow cytometry, using the
APC BrdU Flow Kit (BD Biosciences), pulsing cells for one hour.
Cell Apoptosis assay
Cell apoptosis was detected using the Annexin V PE apoptosis
detection kit (BD Biosciences) following the manufacturer’s protocol.
Tumorigenicity assays:
BxPC-3 cells, transduced with either control or Sulf-2 shRNA
were subcutaneously injected in 6 week nude mice at 5610
6 cells
per site. Tumor growth was monitored every two to three days [7].
SUPPORTING INFORMATION
Figure S1 Sulf promotion of Wnt signaling in a reconstituted
system. HEK 293T cells, stably transfected with either Sulf-1, Sulf-
2 or a control vector, were co-cultured alone or with NIH 3T3
cells that were stably transfected with either Wnt1, Wnt2 or lacZ
control. Wnt signaling in the various HEK 293T cells was
measured by TCF-luciferase reporter activity. Values are normal-
ized to control HEK 293T cells cultured alone.
Found at: doi:10.1371/journal.pone.0000392.s001 (0.49 MB EPS)
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